Related references
Note: Only part of the references are listed.The induction of myeloma cell death and DNA damage by tetrac, a thyroid hormone derivative
Keren Cohen et al.
ENDOCRINE-RELATED CANCER (2018)
The Stem Cell Factor HMGA2 Is Expressed in Non-HPV-Associated Head and Neck Squamous Cell Carcinoma and Predicts Patient Survival of Distinct Subsites
Kathrin Guenther et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
In vitro effects of tetraiodothyroacetic acid combined with X-irradiation on basal cell carcinoma cells
John T. Leith et al.
CELL CYCLE (2017)
Abstract C96: Thyroid hormone induced Beta-catenin-dependent proliferation in colorectal cancer cells
Hung-Yun Lin
MOLECULAR CANCER THERAPEUTICS (2016)
HMGA2 promotes adipogenesis by activating C/EBPβ-mediated expression of PPARγ
Yang Xi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Thyroid Function and Cancer Risk: The Rotterdam Study
Samer R. Khan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Actions of L-thyroxine and Nano-diamino-tetrac (Nanotetrac) on PD-L1 in cancer cells
Hung-Yun Lin et al.
STEROIDS (2016)
The combination of tetraiodothyroacetic acid and cetuximab inhibits cell proliferation in colorectal cancers with different K-ras status
Yee-Shin Lee et al.
STEROIDS (2016)
Anticancer Molecular Mechanisms of Resveratrol
Elena M. Varoni et al.
FRONTIERS IN NUTRITION (2016)
Thyroid Hormone, Cancer, and Apoptosis
Hung-Yun Lin et al.
COMPREHENSIVE PHYSIOLOGY (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Thyroid hormones and tetrac: new regulators of tumour stroma formation via integrin αvβ3
Kathrin A. Schmohl et al.
ENDOCRINE-RELATED CANCER (2015)
Mechanisms of dihydrotestosterone action on resveratrol-induced anti-proliferation in breast cancer cells with different ER status
Yu-Tang Chin et al.
ONCOTARGET (2015)
HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression
Yang Li et al.
CANCER LETTERS (2014)
Resveratrol and cancer: focus on in vivo evidence
Lindsay G. Carter et al.
ENDOCRINE-RELATED CANCER (2014)
Pharmacokinetics and Safety of Resveratrol Derivatives in Humans after Oral Administration of Melinjo (Gnetum gnemon L.) Seed Extract Powder
Hiroko Tani et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2014)
A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma
Rakesh Popat et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
HMGA2 Is a Driver of Tumor Metastasis
Asahiro Morishita et al.
CANCER RESEARCH (2013)
HMGA2 Elicits EMT by Activating the Wnt/β-catenin Pathway in Gastric Cancer
Lang Zha et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
WNT10B/-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer
Peter Wend et al.
EMBO MOLECULAR MEDICINE (2013)
Thyroid hormone, thyroid hormone receptors, and cancer: a clinical perspective
Lars C. Moeller et al.
ENDOCRINE-RELATED CANCER (2013)
Wnt/β-Catenin Signaling and Disease
Hans Clevers et al.
CELL (2012)
Inhibition of pathological retinal angiogenesis by the integrin alpha v beta 3 antagonist tetraiodothyroacetic acid (tetrac)
Takeshi Yoshida et al.
EXPERIMENTAL EYE RESEARCH (2012)
Cell cycle analysis of the CD133 and CD133 - cells isolated from human colorectal cancer
Marjan Gharagozloo et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2012)
Tetraiodothyroacetic acid and its nanoformulation inhibit thyroid hormone stimulation of non-small cell lung cancer cells in vitro and its growth in xenografts
Shaker A. Mousa et al.
LUNG CANCER (2012)
Resveratrol and apoptosis
Hung-Yun Lin et al.
RESVERATROL AND HEALTH (2011)
Clinical trials of resveratrol
Ketan R. Patel et al.
RESVERATROL AND HEALTH (2011)
Overexpression of HMGA2 Promotes Metastasis and Impacts Survival of Colorectal Cancers
Xiaochen Wang et al.
CLINICAL CANCER RESEARCH (2011)
Pharmacodynamic Modeling of Anti-Cancer Activity of Tetraiodothyroacetic Acid in a Perfused Cell Culture System
Hung-Yun Lin et al.
PLOS COMPUTATIONAL BIOLOGY (2011)
Positive regulation of spondin 2 by thyroid hormone is associated with cell migration and invasion
Chen-Hsin Liao et al.
ENDOCRINE-RELATED CANCER (2010)
Selective Synthesis and Biological Evaluation of Sulfate-Conjugated Resveratrol Metabolites
Juma Hoshino et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Resveratrol bioavailability and toxicity in humans
Charles-Henry Cottart et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2010)
Thyroid hormones and cancer: clinical studies of hypothyroidism in oncology
Aleck H. Hercbergs et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2010)
Modification of survival pathway gene expression in human breast cancer cells by tetraiodothyroacetic acid (tetrac)
Anna B. Glinskii et al.
CELL CYCLE (2009)
Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers
Luis Almeida et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2009)
Novel function of the thyroid hormone analog tetraiodothyroacetic acid: a cancer chemosensitizing and anti-cancer agent
Abdelhadi Rebbaa et al.
ANGIOGENESIS (2008)
Resveratrol causes COX-2-and p53-dependent apoptosis in head and neck squamous cell cancer cells
Hung-Yun Lin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Metabolic effects of thyroid hormone derivatives
Maria Moreno et al.
THYROID (2008)
Resveratrol is pro-apoptotic and thyroid hormone is anti-apoptotic in glioma cells: both actions are integrin and ERK mediated
Hung-Yun Lin et al.
CARCINOGENESIS (2008)
Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent
David J. Boocock et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
被撤回的出版物: Thyroid hormone is a MAPK-dependent growth factor for thyroid cancer cells and is anti-apoptotic (Retracted article. See vol. 195, 2023)
Hung-Yun Lin et al.
STEROIDS (2007)
Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo
S Garvin et al.
CANCER LETTERS (2006)
Therapeutic potential of resveratrol: the in vivo evidence
Joseph A. Baur et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats
SH Tseng et al.
CLINICAL CANCER RESEARCH (2004)
High absorption but very low bioavailability of oral resveratrol in humans
T Walle et al.
DRUG METABOLISM AND DISPOSITION (2004)
Chibby, a nuclear β-catenin-associated antagonist of the Wnt/Wingless pathway
KI Takemaru et al.
NATURE (2003)
Requirement for high mobility group protein HMGI-C interaction with STAT3 inhibitor PIAS3 in repression of a-subunit of epithelial Na+ channel (α-ENaC) transcription by Ras activation in salivary epithelial cells
MD Zentner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice
Y Kimura et al.
JOURNAL OF NUTRITION (2001)